← Back to News & Updates

Mark Carnegie-backed biotech Minomic creates better prostate cancer test

Posted by Jessica Gardner on 20/04/ 2015

Mark Carnegie-backed biotech Minomic creates better prostate cancer test

Biotechnology company Minomic has developed a simpler, more accurate blood test for diagnosing prostate cancer, which could reduce the number of men who go onto invasive follow-up tests and suffer plenty of heartache after receiving an initial "false positive" result...

The full article can be accessed here:  AFR Article - Minomic (pdf)